These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. Disease characteristics in patients with juvenile- and adult-onset systemic lupus erythematosus: A multi-center comparative study. Gamal SM; Fouad N; Yosry N; Badr W; Sobhy N Arch Rheumatol; 2022 Jun; 37(2):280-287. PubMed ID: 36017206 [TBL] [Abstract][Full Text] [Related]
26. Comparison of brain and spinal cord magnetic resonance imaging features in neuromyelitis optica spectrum disorders patients with or without aquaporin-4 antibody. Fan M; Fu Y; Su L; Shen Y; Wood K; Yang L; Liu Y; Shi FD Mult Scler Relat Disord; 2017 Apr; 13():58-66. PubMed ID: 28427704 [TBL] [Abstract][Full Text] [Related]
27. Juvenile- and adult-onset systemic lupus erythematosus: a comparative study in a large cohort from the Spanish Society of Rheumatology Lupus Registry (RELESSER). Torrente-Segarra V; Salman Monte TC; Rúa-Figueroa I; Sánchez-Alonso F; López-Longo FJ; Galindo-Izquierdo M; Calvo-Alén J; Olivé-Marqués A; Ibañez-Ruán J; Horcada L; Sánchez-Atrio A; Montilla C; Melero González RB; Díez-Álvarez E; Martinez-Taboada V; Andreu JL; Fernández-Berrizbeitia O; Hernández-Beriain JÁ; Gantes M; Hernández-Cruz B; Pecondón-Español Á; Marras C; Bonilla G; Pego-Reigosa JM; Clin Exp Rheumatol; 2017; 35(6):1047-1055. PubMed ID: 28628467 [TBL] [Abstract][Full Text] [Related]
28. Change in autoantibody and cytokine responses during the evolution of neuromyelitis optica in patients with systemic lupus erythematosus: A preliminary study. Kovacs KT; Kalluri SR; Boza-Serrano A; Deierborg T; Csepany T; Simo M; Rokusz L; Miseta A; Alcaraz N; Czirjak L; Berki T; Molnar T; Hemmer B; Illes Z Mult Scler; 2016 Aug; 22(9):1192-201. PubMed ID: 26514978 [TBL] [Abstract][Full Text] [Related]
29. Increased serum sFas, sTRAIL, and reduced sFasL in juvenile-onset systemic lupus erythematosus. Liphaus BL; Kiss MHB; Carrasco S; Palmeira P; Goldenstein-Schainberg C; Carneiro-Sampaio M Clin Rheumatol; 2017 Dec; 36(12):2847-2852. PubMed ID: 28378099 [TBL] [Abstract][Full Text] [Related]
30. Neuropsychiatric lupus in Malaysian children: clinical characteristics, imaging features and 12-month outcomes. Lim SC; Md-Yusof YL; Johari B; Abdul-Kadir RF; Tang SP Turk J Pediatr; 2021; 63(5):743-751. PubMed ID: 34738356 [TBL] [Abstract][Full Text] [Related]
31. Aquaporin-4-autoimmunity in patients with systemic lupus erythematosus: A predominantly population-based study. Asgari N; Jarius S; Laustrup H; Skejoe HP; Lillevang ST; Weinshenker BG; Voss A Mult Scler; 2018 Mar; 24(3):331-339. PubMed ID: 28326889 [TBL] [Abstract][Full Text] [Related]
32. The incidence, diagnostic clinical manifestations and severity of juvenile systemic lupus erythematosus in New Zealand Maori and Pacific Island children: the Starship experience (2000-2010). Concannon A; Rudge S; Yan J; Reed P Lupus; 2013 Oct; 22(11):1156-61. PubMed ID: 24003079 [TBL] [Abstract][Full Text] [Related]
33. Longitudinally extensive transverse myelitis with and without aquaporin 4 antibodies. Kitley J; Leite MI; Küker W; Quaghebeur G; George J; Waters P; Woodhall M; Vincent A; Palace J JAMA Neurol; 2013 Nov; 70(11):1375-81. PubMed ID: 23999580 [TBL] [Abstract][Full Text] [Related]
34. Impact of comorbid Sjögren syndrome in anti-aquaporin-4 antibody-positive neuromyelitis optica spectrum disorders. Akaishi T; Takahashi T; Fujihara K; Misu T; Fujimori J; Takai Y; Nishiyama S; Abe M; Ishii T; Aoki M; Nakashima I J Neurol; 2021 May; 268(5):1938-1944. PubMed ID: 33416998 [TBL] [Abstract][Full Text] [Related]
35. Neuromyelitis optica spectrum disorders with antibodies to myelin oligodendrocyte glycoprotein or aquaporin-4: Clinical and paraclinical characteristics in Algerian patients. Bouzar M; Daoudi S; Hattab S; Bouzar AA; Deiva K; Wildemann B; Reindl M; Jarius S J Neurol Sci; 2017 Oct; 381():240-244. PubMed ID: 28991690 [TBL] [Abstract][Full Text] [Related]
36. Frequency of autoimmune disorders and autoantibodies in patients with neuromyelitis optica. Pereira WLCJ; Reiche EMV; Kallaur AP; Oliveira SR; Simão ANC; Lozovoy MAB; Schiavão LJV; Rodrigues PRDVP; Alfieri DF; Flauzino T; Kaimen-Maciel DR Acta Neuropsychiatr; 2017 Jun; 29(3):170-178. PubMed ID: 27692000 [TBL] [Abstract][Full Text] [Related]
37. Diagnostic performance and clinical associations of antibodies to the chromatin antigenic system in juvenile systemic lupus erythematosus. Keusseyan SP; da Silva NP; Hilário MO; Okuda EM; Terreri MT; Andrade LE Rev Bras Reumatol; 2012 Oct; 52(5):695-712. PubMed ID: 23090370 [TBL] [Abstract][Full Text] [Related]
38. The clinical value of complement proteins in differentiating AQP4-IgG-positive from MOG-IgG-positive neuromyelitis optica spectrum disorders. Qin C; Chen B; Tao R; Chen M; Ma X; Shang K; Wu LJ; Wang W; Bu BT; Tian DS Mult Scler Relat Disord; 2019 Oct; 35():1-4. PubMed ID: 31276911 [TBL] [Abstract][Full Text] [Related]